Earnings Per Share, Basic of TENAX THERAPEUTICS, INC. from 31 Jul 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
TENAX THERAPEUTICS, INC. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 31 Jul 2010 to 30 Sep 2025.
  • TENAX THERAPEUTICS, INC. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -0.4, a 111% decline year-over-year.
  • TENAX THERAPEUTICS, INC. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was 3.
  • TENAX THERAPEUTICS, INC. annual Earnings Per Share, Basic for 2024 was -1.15, a 96% increase from 2023.
  • TENAX THERAPEUTICS, INC. annual Earnings Per Share, Basic for 2023 was -31.04.
  • TENAX THERAPEUTICS, INC. annual Earnings Per Share, Basic for 2014 was -0.5, a 82% increase from 2013.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

TENAX THERAPEUTICS, INC. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 3 -0.4 -0.21 -111% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 3 -0.27 +1.56 +85% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 1 -0.28 +2.84 +91% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 -1 3.99 01 Oct 2024 31 Dec 2024 10-K 25 Mar 2025 2024 FY
Q3 2024 -0.19 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 -1.83 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 -3.12 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2015 0 -0.18 -1.19 -118% 01 Feb 2015 30 Apr 2015 10-KT 14 Mar 2016 2015 FY
Q4 2014 0 -0.1 +0.33 +77% 01 Nov 2014 31 Jan 2015 10-Q 17 Mar 2015 2015 Q3
Q3 2014 0 -0.14 +1.09 +89% 01 Aug 2014 31 Oct 2014 10-Q 15 Dec 2014 2015 Q2
Q2 2014 0 -0.08 +1.98 +96% 01 May 2014 31 Jul 2014 10-Q 15 Sep 2014 2015 Q1
Q1 2014 -2 1.01 +2.5 01 Feb 2014 30 Apr 2014 10-KT 14 Mar 2016 2015 FY
Q4 2013 -5 -0.43 +1.02 +70% 01 Nov 2013 31 Jan 2014 10-Q 17 Mar 2015 2015 Q3
Q3 2013 -6 -1.23 -0.26 -27% 01 Aug 2013 31 Oct 2013 10-Q 15 Dec 2014 2015 Q2
Q2 2013 -5 -2.06 +0.32 +13% 01 May 2013 31 Jul 2013 10-Q 15 Sep 2014 2015 Q1
Q1 2013 -6 -1.49 +10.13 +87% 01 Feb 2013 30 Apr 2013 10-KT 14 Mar 2016 2015 FY
Q4 2012 -16 -1.45 -1.19 -458% 01 Nov 2012 31 Jan 2013 10-Q 17 Mar 2014 2014 Q3
Q3 2012 -15 -0.97 -0.85 -708% 01 Aug 2012 31 Oct 2012 10-Q 17 Dec 2013 2014 Q2
Q2 2012 -14 -2.38 -2.26 -1883% 01 May 2012 31 Jul 2012 10-Q 17 Sep 2013 2014 Q1
Q1 2012 -12 -11.62 -11.5 -9583% 01 Feb 2012 30 Apr 2012 10-K 26 Jun 2013 2013 FY
Q4 2011 0 -0.26 -0.15 -136% 01 Nov 2011 31 Jan 2012 10-Q 18 Mar 2013 2013 Q3
Q3 2011 0 -0.12 -0.03 -33% 01 Aug 2011 31 Oct 2011 10-Q 14 Dec 2012 2013 Q2
Q2 2011 0 -0.12 +0.01 +7.7% 01 May 2011 31 Jul 2011 10-Q 19 Sep 2012 2013 Q1
Q1 2011 0 -0.12 01 Feb 2011 30 Apr 2011 10-K 25 Jul 2012 2012 FY
Q4 2010 -0.11 01 Nov 2010 31 Jan 2011 10-Q 15 Mar 2012 2012 Q3
Q3 2010 -0.09 01 Aug 2010 31 Oct 2010 10-Q 15 Dec 2011 2012 Q2
Q2 2010 -0.13 01 May 2010 31 Jul 2010 10-Q 19 Sep 2011 2012 Q1

TENAX THERAPEUTICS, INC. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 -1.15 +29.89 +96% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025 2024 FY
2023 -31.04 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
2014 -0.5 +2.21 +82% 01 May 2014 30 Apr 2015 10-KT 14 Mar 2016 2015 FY
2013 -2.71 +3.58 +57% 01 May 2013 30 Apr 2014 10-KT 14 Mar 2016 2015 FY
2012 -6.29 +5.83 +48% 01 May 2012 30 Apr 2013 10-KT 14 Mar 2016 2015 FY
2011 -12.12 -11.67 -2593% 01 May 2011 30 Apr 2012 10-K 26 Jun 2013 2013 FY
2010 -0.45 01 May 2010 30 Apr 2011 10-K 25 Jul 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.